Dallah Healthcare Co. reported a net profit of SAR 421.7 million for the first nine months of 2025, up 18% from SAR 357.3 million a year earlier.
| Item | 9m 2024 | 9m 2025 | Change |
|---|---|---|---|
| Revenues | 2,396.97 | 2,956.45 | 23.3 % |
| Gross Income | 914.08 | 1,054.11 | 15.3 % |
| Operating Income | 451.72 | 490.48 | 8.6 % |
| Net Income | 357.30 | 421.72 | 18.0 % |
| Average Shares | 97.68 | 99.93 | 2.3 % |
| Earnings Per Share before unusual items (Riyals) | 3.66 | 3.29 | (10.2 %) |
| EPS (Riyal) | 3.66 | 4.22 | 15.4 % |
Revenue rose 23.3% to SAR 2.96 billion in the nine-month period, compared with SAR 2.4 billion in the same period last year. Earnings per share rose to SAR 4.22 from SAR 3.66.
Gross profit rose 15.3% to SAR 1.05 billion, compared with SAR 914 million in the year-earlier period, an increase of SAR 140 million. Operating profit also improved 8.6% to SAR 490 million, compared with SAR 452 million a year earlier, an increase of SAR 39 million.
Net profit before finance costs, amortization, depreciation, and zakat rose 17% to SAR 685 million from SAR 585 million, an increase of SAR 100 million.
| Item | Q3 2024 | Q3 2025 | Change |
|---|---|---|---|
| Revenues | 847.73 | 1,061.26 | 25.2 % |
| Gross Income | 322.99 | 380.62 | 17.8 % |
| Operating Income | 161.42 | 157.59 | (2.4 %) |
| Net Income | 126.15 | 141.90 | 12.5 % |
| Average Shares | 97.68 | 99.93 | 2.3 % |
| Earnings Per Share before unusual items (Riyal) | 1.29 | 1.12 | (12.9 %) |
| EPS (Riyal) | 1.29 | 1.42 | 9.9 % |
| Item | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Revenues | 1,062.43 | 1,061.26 | (0.1 %) |
| Gross Income | 375.88 | 380.62 | 1.3 % |
| Operating Income | 154.99 | 157.59 | 1.7 % |
| Net Income | 124.26 | 141.90 | 14.2 % |
| Average Shares | 99.93 | 99.93 | - |
| Earnings Per Share before unusual items (Riyal) | 1.12 | 1.12 | 0.6 % |
| EPS (Riyal) | 1.24 | 1.42 | 14.2 % |
Dallah Healthcare’s third-quarter net profit grew 12.5% to SAR 141.9 million, from SAR 126.15 million in Q3 2024.
Sequentially, the three-month bottom line increased 14.2% from SAR 124.26 million in Q2 2025.
Total shareholders’ equity, after minority interest, increased to SAR 4.22 billion at the end of Sept. 30, 2025, from SAR 3.41 billion in the year-earlier period.
Attached Documents
| Company | Estimated | Actual | Change |
|---|---|---|---|
| STC | 3,604.78 | 4,107.00 | |
| HERFY FOODS | (6.00) | (48.13) | |
| CENOMI CENTERS | 288.75 | 502.43 | |
| DALLAH HEALTH | 130.37 | 141.90 | |
| ADES | 206.80 | 214.57 | |
| RIYADH CABLES | 287.52 | 283.53 | |
| ACWA POWER | 546.85 | 371.17 | |
| SAUDI GERMAN HEALTH | 62.17 | 40.29 | |
| SPIMACO | 52.00 | 43.60 | |
| EPCCO | 46.88 | 36.00 |
| Company | Estimated | Actual | Change |
|---|---|---|---|
| STC | 3,604.78 | 3,633.00 | |
| HERFY FOODS | (6.00) | (11.93) | |
| CENOMI CENTERS | 288.75 | 72.53 | |
| DALLAH HEALTH | 130.37 | 112.40 | |
| ADES | 206.80 | 214.57 | |
| RIYADH CABLES | 287.52 | 283.53 | |
| ACWA POWER | 546.85 | 182.17 | |
| SAUDI GERMAN HEALTH | 62.17 | 40.29 | |
| SPIMACO | 52.00 | 43.60 | |
| EPCCO | 46.88 | 36.00 |
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website

Comments Analysis: